TY - JOUR
T1 - Interferon-α triggers autoimmune thyroid diseases via lysosomal-dependent degradation of thyroglobulin
AU - Faustino, Larissa C.
AU - Lombardi, Angela
AU - Madrigal Matute, Julio
AU - Owen, Randall P.
AU - Libutti, Steven K.
AU - Tomer, Yaron
N1 - Funding Information:
Financial Support: This work was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK061659, DK067555, and DK073681 to Y.T.). J.M.-M. is supported by a postdoctoral fellowship from the American Diabetes Association (Grant 1-15-MI-03) and by the Leducq Foundation Transatlantic Network of Excellence.
Publisher Copyright:
© 2018 Oxford University Press. All rights reserved.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Context: Autoimmune thyroid diseases (AITDs) arise from complex interactions among genetic, epigenetic, and environmental factors. Thyroglobulin (TG) is a major susceptibility gene for both Graves disease and Hashimoto thyroiditis. Interferon-A (IFNa), a cytokine secreted during viral infections, has emerged as a key trigger of AITD. We have shown that IFNa upregulates TG transcription; however, how the upregulation of TG transcription by IFNa triggers AITD is still unknown. Objective: To evaluate how IFNa triggers AITD by testing its effects on TG processing. Design: We exposed human thyroid cells to IFNa and evaluated its effects on TG expression and processing. Results: Human thyroid cells exposed to INFa had increased levels of TG mRNA but reduced TG protein levels, indicating TG protein degradation. IFNa induced endoplasmic reticulum stress, but surprisingly, neither the use of chemical chaperones nor proteasome inhibitor prevented IFNainduced TG degradation. IFNa also increased LysoTracker staining and autophagy flux measured by net light chain 3 (LC3)-II and p62 fluxes. In addition, expression of autophagy markers LC3 and autophagy-related gene 5 was higher in thyroid tissues from patients with AITD. Finally, blocking lysosomal degradation prevented IFNa-induced degradation of TG. Conclusion: We have shown in this study IFNa-induced lysosomal-dependent degradation of TG in human thyroid cells. Our findings suggest that during viral infections, local thyroidal IFNa production can lead to lysosomal TG degradation, releasing pathogenic TG peptides that can trigger AITD.
AB - Context: Autoimmune thyroid diseases (AITDs) arise from complex interactions among genetic, epigenetic, and environmental factors. Thyroglobulin (TG) is a major susceptibility gene for both Graves disease and Hashimoto thyroiditis. Interferon-A (IFNa), a cytokine secreted during viral infections, has emerged as a key trigger of AITD. We have shown that IFNa upregulates TG transcription; however, how the upregulation of TG transcription by IFNa triggers AITD is still unknown. Objective: To evaluate how IFNa triggers AITD by testing its effects on TG processing. Design: We exposed human thyroid cells to IFNa and evaluated its effects on TG expression and processing. Results: Human thyroid cells exposed to INFa had increased levels of TG mRNA but reduced TG protein levels, indicating TG protein degradation. IFNa induced endoplasmic reticulum stress, but surprisingly, neither the use of chemical chaperones nor proteasome inhibitor prevented IFNainduced TG degradation. IFNa also increased LysoTracker staining and autophagy flux measured by net light chain 3 (LC3)-II and p62 fluxes. In addition, expression of autophagy markers LC3 and autophagy-related gene 5 was higher in thyroid tissues from patients with AITD. Finally, blocking lysosomal degradation prevented IFNa-induced degradation of TG. Conclusion: We have shown in this study IFNa-induced lysosomal-dependent degradation of TG in human thyroid cells. Our findings suggest that during viral infections, local thyroidal IFNa production can lead to lysosomal TG degradation, releasing pathogenic TG peptides that can trigger AITD.
UR - http://www.scopus.com/inward/record.url?scp=85054449227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054449227&partnerID=8YFLogxK
U2 - 10.1210/jc.2018-00541
DO - 10.1210/jc.2018-00541
M3 - Article
C2 - 30113675
AN - SCOPUS:85054449227
SN - 0021-972X
VL - 103
SP - 3678
EP - 3687
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 10
ER -